This role is a key contributor to how senior management, the Board, and investors understand portfolio performance. The Analyst / Senior Analyst will transform leasing, occupancy, and development data into actionable analysis and reporting that supports executive decision-making.
This position offers a strong opportunity for a finance professional who enjoys working at the intersection of data, reporting, and business insight. The role includes ownership of recurring executive and investor deliverables, ad hoc portfolio analysis, and collaboration with teams across the company to help explain what is happening in the business. It is well suited for someone who is highly analytical, detail-oriented, and comfortable operating in a fast-paced environment with multiple priorities.
Title and level will be determined based on experience, skill set, and demonstrated ability in financial reporting, analysis, and cross-functional partnership.
BioMed Realty is an equal opportunity employer. Employment decisions are made based on individual qualifications, job-related requirements, and business needs, without regard to race, color, religion, sex (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity or expression, age, national origin, ancestry, disability, marital status, veteran or military status, or any other characteristic protected by applicable law.
Data Synthesis: Coordinates data from multiple sources and consolidates it into a unified reporting structure, while maintaining an understanding of source data and downstream reporting impacts
Unlock the Full Role
See the structured details that can help you decide how to apply and prepare.
BioMed Realty, a Blackstone portfolio company, is the largest private provider of real estate solutions for the life science industry. BioMed owns and operates high-quality life science real estate in leading innovation markets across the United States and the United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder, and Cambridge, U.K.
BioMed Realty, a Blackstone portfolio company, is a leading provider of real estate solutions to the life science and technology industries. As of September 30, 2025, BioMed Realty owns and operates high-quality life science real estate comprising more than 17 million square feet concentrated in leading innovation markets throughout the United States and the United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder and Cambridge, U.K. In addition, BioMed Realty maintains a premier development platform with 1.5 million square feet of Class A properties in active construction to meet the demand of the life science and technology industries.